RIPK1 and nervous system disorder: Necrostatin-1 (Nec), as the first specific inhibitor of RIPK1, has been extensively demonstrated to possess noticeable effects on inhibiting necroptosis in various diseases, including inflammatory cardiovascular, neurological diseases, etc. [23].